These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14959510)

  • 41. [In cases of familial ovarian cancer, always consider the risk of breast cancer].
    Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
    Konstantopoulou I; Rampias T; Ladopoulou A; Koutsodontis G; Armaou S; Anagnostopoulos T; Nikolopoulos G; Kamakari S; Nounesis G; Stylianakis A; Karanikiotis C; Razis E; Gogas H; Keramopoulos A; Gaki V; Markopoulos C; Skarlos D; Pandis N; Bei T; Arzimanoglou I; Fountzilas G; Yannoukakos D
    Breast Cancer Res Treat; 2008 Feb; 107(3):431-41. PubMed ID: 17453335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hereditary breast cancer and genetic counseling in young women.
    Brunet J
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():7-9. PubMed ID: 20711663
    [No Abstract]   [Full Text] [Related]  

  • 45. Genetic testing by cancer site: ovary.
    Weissman SM; Weiss SM; Newlin AC
    Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    Stuckey AR; Onstad MA
    Am J Obstet Gynecol; 2015 Aug; 213(2):161-5. PubMed ID: 25747548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.
    de Jong MM; Nolte IM; te Meerman GJ; van der Graaf WT; Oosterwijk JC; Kleibeuker JH; Schaapveld M; de Vries EG
    J Med Genet; 2002 Apr; 39(4):225-42. PubMed ID: 11950848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of breast and ovarian cancer in women with strong family histories.
    Srivastava A; McKinnon W; Wood ME
    Oncology (Williston Park); 2001 Jul; 15(7):889-902; discussion 902, 905-7, 911-13. PubMed ID: 11499690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hereditary cancers in obstetrics and gynecology.
    Swisher E
    Clin Obstet Gynecol; 2001 Sep; 44(3):450-63. PubMed ID: 11685871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hereditary breast and ovarian cancer: primary and secondary prevention for BRCA1 and BRCA2 mutation carriers].
    Llort G; Peris M; Blanco I
    Med Clin (Barc); 2007 Mar; 128(12):468-76. PubMed ID: 17408542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oophorectomy in carriers of BRCA mutations.
    Peshkin BN; DeMarco TA; Schwartz MD
    N Engl J Med; 2002 Sep; 347(13):1037-40; author reply 1037-40. PubMed ID: 12353511
    [No Abstract]   [Full Text] [Related]  

  • 52. [Epidemiology and genetics of cancers of the ovary].
    Vidal V; Bignon YJ
    Rev Prat; 1997 Jun; 47(11):1182-6. PubMed ID: 9238812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of testing for breast cancer susceptibility genes.
    Holland ML; Huston A; Noyes K
    Value Health; 2009; 12(2):207-16. PubMed ID: 18647256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Translational advances regarding hereditary breast cancer syndromes.
    Gage M; Wattendorf D; Henry LR
    J Surg Oncol; 2012 Apr; 105(5):444-51. PubMed ID: 22441895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [What attitude to women at high risk of breast cancer?].
    Livon D; Moretta J; Noguès C
    Presse Med; 2019 Oct; 48(10):1092-1100. PubMed ID: 31706893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic/familial high-risk assessment: breast and ovarian.
    Daly MB; Axilbund JE; Buys S; Crawford B; Farrell CD; Friedman S; Garber JE; Goorha S; Gruber SB; Hampel H; Kaklamani V; Kohlmann W; Kurian A; Litton J; Marcom PK; Nussbaum R; Offit K; Pal T; Pasche B; Pilarski R; Reiser G; Shannon KM; Smith JR; Swisher E; Weitzel JN;
    J Natl Compr Canc Netw; 2010 May; 8(5):562-94. PubMed ID: 20495085
    [No Abstract]   [Full Text] [Related]  

  • 57. Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis.
    Tengs TO; Winer EP; Paddock S; Aguilar-Chavez O; Berry DA
    Med Decis Making; 1998; 18(4):365-75. PubMed ID: 10372578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Germ line mutations associated with breast cancer susceptibility.
    Iau PT; Macmillan RD; Blamey RW
    Eur J Cancer; 2001 Feb; 37(3):300-21. PubMed ID: 11239752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current and future role of genetic screening in gynecologic malignancies.
    Ring KL; Garcia C; Thomas MH; Modesitt SC
    Am J Obstet Gynecol; 2017 Nov; 217(5):512-521. PubMed ID: 28411145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Management of families at high risk for hereditary breast-ovarian cancers: the endocrinologist's point of view].
    Courtillot C; Touraine P
    Ann Endocrinol (Paris); 2008 Jun; 69(3):193-200. PubMed ID: 18294609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.